Global vaccine adjuvants market size to surpass USD 1,305 million mark by 2027

Market Study Report, LLC.
·8 min read

The research report on ‘vaccine adjuvants market’ comprises of crucial insights pertaining to this business landscape and highlights the growth factors, limitations & restraints, and expansion opportunities impacting the overall industry outlook during 2020-2026.

Selbyville, Delaware , Oct. 27, 2020 (GLOBE NEWSWIRE) -- According to reliable estimates, global vaccine adjuvants market is expected to reach a valuation of USD 1,305.7 million by the year 2027. The growth is primarily attributed to increased pervasiveness of infectious diseases such as MERS (Middle East Respiratory Syndrome), Ebola Virus, SARS, and the currently ongoing COVID-19 pandemic. Improved participation of biopharma companies along with rising R&D activities are also facilitating the overall business scenario.

For those uninitiated, adjuvants are used for producing vaccines in order to improve their efficacy in developing a superior immune system in the patient. These vaccines are usually made from weakened germs which comprise of naturally occurring adjuvants for better immunogenicity. In this context, introduction of various immunization programs by governments across the globe coupled with increasing number of untreated diseases are augmenting global vaccine adjuvants industry remuneration.

Adjuvants also help in lowering the number of repeated vaccinations and enhances antibody reactions such as T-cell response, further stimulating the industry outlook. However, concerns regarding the side effects associated with vaccine adjuvants such as lethargy, myalgia, headache, diarrhea, malaise, arthralgia, fever, and nausea may negatively impact worldwide vaccine adjuvants market trends in the forthcoming years.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2963841/

Product terrain

Industry experts cite that adjuvant emulsions segment accounted for majority of vaccine adjuvants market share in the year 2019 and is expected to display similar growth trends in the forthcoming years. Adjuvant emulsions possess better clinical effectiveness as compared to its counterparts owing to their small droplet size which allows immune cells to respond quickly by triggering the innate immunity of the patient. Thus, high occurrence of allergic reactions along with increasing emphasis of pharmaceutical companies towards development of vaccines with better efficiency are fueling adjuvant emulsions segmental share.

Route of administration

Sources claim that intramuscular segment held the largest share in global vaccines adjuvants market in the year 2019. Majority of vaccines currently in use are administered intramuscular. As a matter of fact, various government-based immunization programs use intramuscular route of administration, thereby boosting the demand for adjuvants intramuscular vaccines.

Meanwhile, intradermal segment is predicted to record the highest CAGR through 2027. Experts cite that the skin layer is made up of immunologically supported APCs (antigen presenting cells) which help in increasing the efficacy of the drug, in turn contributing to the popularity of intradermal vaccines.

Disease type

Global vaccine adjuvants industry size from infectious diseases segment is estimated to grow substantially during the forecast period. The growth can be credited to rising prevalence of infectious diseases and focus among government organizations towards conducting research & development for vaccines of cancer as well as autoimmune diseases.

Application Scope

Worldwide vaccine adjuvants market share from research application segment is slated to witness considerable growth during the study duration. Increased pervasiveness of zoonotic diseases and emphasis on R&D activities in order to improve the effectiveness of drugs are adding traction to the overall market size.

To access a sample copy or view this report in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/vaccine-adjuvants-market-share-size-trends-industry-analysis-report-by-product-type-mineral-salt-based-adjuvant-tensoactive-adjuvants-adjuvant-emulsions-liposome-adjuvants-carbohydrate-adjuvants-bacteria-derived-adjuvants-virus-like-particles-vlp-and-other-types-by-route-of-administration-oral-subcutaneous-intranasal-intramuscular-intradermal-and-others-by-disease-types-by-application-research-application-and-commercial-application-by-regions-segment-forecast-2020-2027

Geographical Landscape

According to industry experts, North America is anticipated to lead global vaccine adjuvants market expansion in the subsequent years. High concentration of bio-pharmaceutical companies, increasing government funding, and rising number of COVID-19 patients in the United States are key factors augmenting North America vaccine adjuvants industry share.

Parallelly, Europe vaccine adjuvants market is also predicted to expand significantly during the study period. High occurrence of COVID-19 in the region has compelled various public as well as private entities to focus on developing a cure in order to lower the mortality rate, thereby positively impacting the overall market outlook in Europe.

Asia-Pacific is predicted to emerge as a major revenue pocket for global vaccine adjuvants market players during the estimated timeframe. Supportive government initiatives for addressing the rising number of COVID-19 cases, especially in Australia, South Korea, China, and India is complementing the business scenario in APAC.

Global Vaccine Adjuvants Market by Product Type (Revenue, USD Million, 2016-2027)

  • Bacteria-derived Adjuvants

  • Carbohydrate Adjuvants

  • Virus-like Particles (VLP)

  • Liposome Adjuvants

  • Mineral Salt-based Adjuvant

  • Adjuvant Emulsions

  • Tensoactive Adjuvants

  • Others

Global Vaccine Adjuvants Market by Route of Administration (Revenue, USD Million, 2016-2027)

  • Intramuscular

  • Oral

  • Intranasal

  • Intradermal

  • Subcutaneous

  • Others

Global Vaccine Adjuvants Market by Disease Type (Revenue, USD Million, 2016-2027)

  • Cancer

  • Rare Diseases

  • Autoimmune Disorders

  • Infectious Diseases

  • Others

Global Vaccine Adjuvants Market by Application Reach (Revenue, USD Million, 2016-2027)

  • Commercial Application

  • Research Application

Global Vaccine Adjuvant Market Regional Analysis (Revenue, USD Million, 2016-2027)

North America

  • Canada

  • U.S.

Europe

  • Belgium

  • Spain

  • Italy

  • Germany

  • France

  • U.K.

  • Austria

Asia-Pacific

  • Malaysia

  • South Korea

  • Japan

  • India

  • China

  • Australia

Middle East & Africa

  • South Africa

  • Israel

  • UAE

  • Saudi Arabia

Central & South America

  • Argentina

  • Brazil

  • Mexico

Global Vaccine Adjuvants Market Competitive Scenario (Revenue, USD Million, 2016-2027)

  • Aphios Corporation

  • Adjuvants Unlimited Inc.

  • Adjuvants Euclid Canada Inc.

  • OZ Biosciences

  • Novavax Inc.

  • Adjuvatis

  • Sanofi Pasteur

  • Moderna Inc.

  • GlaxoSmithKline plc

  • Sergeant Adjuvants

  • SPI Pharma

Table of Contents

1. Introduction

1.1. Report Description

1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview

3.1.1. Data Mining

3.2. Data Sources

3.2.1. Primary Sources

3.2.2. Secondary Sources

4. Vaccine Adjuvants Market Insights

4.1. Vaccine Adjuvant - Industry snapshot

4.2. Vaccine Adjuvants Market Dynamics

4.2.1. Drivers and Opportunities

4.2.1.1. Surge in the infectious diseases

4.2.1.2. Government sponsored immunization programs

4.2.2. Restraints and Challenges

4.2.2.1. Side effects associated with the usage of adjuvants

4.3. Porter's Five Forces Analysis

4.4. PESTLE Analysis

4.5. Vaccine Adjuvants Market Industry trends

5. Vaccine Adjuvants Market Assessment by Product Type

5.1. Key Findings

5.2. Introduction

5.2.1. Global Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)

5.3. Mineral Salt-based Adjuvant

5.3.1. Global Vaccine Adjuvants Market, by Mineral Salt-based Adjuvant, by Region, 2016- 2027 (USD Million)

5.4. Tensoactive Adjuvants

5.4.1. Global Vaccine Adjuvants Market, by Tensoactive Adjuvants, by Region, 2016- 2027 (USD Million)

5.5. Adjuvant Emulsions

5.5.1. Global Vaccine Adjuvants Market, by Adjuvant Emulsions, by Region, 2016- 2027 (USD Million)

5.6. Liposome Adjuvants

5.6.1. Global Vaccine Adjuvants Market, by Liposome Adjuvants, by Region, 2016- 2027 (USD Million)

5.7. Carbohydrate Adjuvants

5.7.1. Global Vaccine Adjuvants Market, by Carbohydrate Adjuvants, by Region, 2016- 2027 (USD Million)

5.8. Bacteria-derived Adjuvants

5.8.1. Global Vaccine Adjuvants Market, by Bacteria-derived Adjuvants, by Region, 2016- 2027 (USD Million)

5.9. Virus-like Particles (VLP)

6. Global Vaccine Adjuvants Market, by Route of Administration

6.1. Key Findings

6.2. Introduction

6.3. Oral

6.4. Subcutaneous

6.5. Intranasal

6.6. Intramuscular

6.7. Intradermal

7. Global Vaccine Adjuvants Market, by Disease Type

7.1. Key Findings

7.2. Introduction

7.3. Infectious Diseases

7.4. Rare Diseases

7.5. Cancer

7.6. Autoimmune Disorders

8. Vaccine Adjuvants Market Assessment by Application

8.1. Key Findings

8.2. Introduction

8.3. Research Application

8.4. Commercial Application

9. Vaccine Adjuvants Market Assessment by Geography

Related Report:

North America COVID-19 Detection Kits Market Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026

North America COVID-19 Detection Kits Market value is set to exceed USD 1.7 billion by 2026, as per new research report. The rising number of coronavirus positive cases will serve to a key impact rendering factor for North America COVID-19 detection kits market growth over the forecast period. After China and Italy, U.S. rapidly climbed the ladder to become the epicenter of global COVID-19 pandemic, with the highest number of COVID-19 positive cases. With the rapidly spreading COVID-19 disease throughout the continent, the demand for COVID-19 detection kits is expected to witness robust growth over the forecast timeframe.

North America region is expected to witness a rapid expansion of the geriatric population segment over the forecast period. As the geriatric population base expands, the demand for accurate and early diagnosis of COVID-19 infection will rise to render a significant positive impact on industry growth. However, low accuracy of immunoassay-based detection kits will impede the North America COVID-19 detection kits market growth to some extent over the forecast timeframe.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

CONTACT: Contact Us: Corporate Sales, Market Study Report LLC Phone: 1-302-273-0910 Toll Free: 1-866-764-2150 Email: sales@marketstudyreport.com News: https://www.newsorigins.com/